Stay updated on Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page now shows revision v3.5.4, replacing v3.5.3. This indicates a small platform update and does not alter the study details or how users interact with the page.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, reflecting a different release/version of the website interface rather than a change to the clinical trial details.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision history updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedA new site revision label 'Revision: v3.4.2' was added and a general funding/operating status notice previously displayed on the page was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.